Paper Details

  1. Home
  2. Paper Details

Pimitespib for the treatment of advanced gastrointestinal stromal tumors and other tumors.

Author: DoiToshihiko, OhkuboShuichi, YamamotoNoboru

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review examines pimitespib, a heat shock protein 90 (HSP90) inhibitor approved for treating gastrointestinal stromal tumors (GIST) that have progressed after other treatments. Pimitespib significantly prolonged progression-free survival compared to placebo in a phase III study. Common side effects included diarrhoea, decreased appetite, and increased serum creatinine. The review also discusses ongoing research into pimitespib's efficacy and safety in other tumor types and in combination with other anticancer therapies.
Paper Details　
Original Abstract of the Article :
Pimitespib (TAS-116) is the first heat shock protein 90 (HSP90) inhibitor approved in Japan, and it is indicated for the treatment of gastrointestinal stromal tumors (GIST) that have progressed after treatment with imatinib, sunitinib and regorafenib. This review describes the preclinical and clinic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2217/fon-2022-1172

データ提供：米国国立医学図書館（NLM）

Pimitespib: A New Hope for Gastrointestinal Stromal Tumors

This research dives deep into the world of [oncology], specifically focusing on the treatment of [Gastrointestinal Stromal Tumors (GISTs)]. It examines the effectiveness of [Pimitespib], a revolutionary [heat shock protein 90 (HSP90) inhibitor], in battling these tumors. The study highlights the use of [clinical trials] to analyze the drug's [mechanism of action, pharmacokinetics, antitumor activity, and safety]. The researchers discovered that Pimitespib significantly extended [progression-free survival] compared to a placebo, offering a glimmer of hope for patients with advanced GISTs.

A Ray of Hope for GIST Patients

The study revealed that Pimitespib significantly extended [progression-free survival] compared to a placebo, showcasing its potential in fighting advanced GISTs. This breakthrough offers a beacon of hope for patients struggling with this aggressive disease. Imagine a vast desert with an oasis – this is how this drug represents a lifeline for GIST patients, providing them with a chance to fight for longer.

Navigating the Side Effects

While this new drug is promising, it comes with some [side effects] like [diarrhea, decreased appetite, increased serum creatinine, malaise, nausea, and eye disorders]. Just as a camel navigates the treacherous desert, patients must understand and manage these side effects to ensure the best possible outcome.

Dr.Camel's Conclusion

This study shines a light on the potential of [Pimitespib] in the treatment of [GISTs]. While the desert of cancer research is vast, Pimitespib offers a promising oasis for patients, providing hope for a longer and healthier life. Further research is essential to understand its long-term implications and explore its potential in combination with other therapies.
Date :
  1. Date Completed n.d.
  2. Date Revised 2023-12-05
Further Info :

Pubmed ID

38050698

DOI: Digital Object Identifier

10.2217/fon-2022-1172

Related Literature

Article Analysis
・Side Effects of sunitinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.